Reduced levels of Aβ 40 and Aβ 42 in brains of smoking controls and Alzheimer's patients
- 1 March 2004
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 15 (2) , 351-360
- https://doi.org/10.1016/j.nbd.2003.11.024
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Amyloid 1-42 peptide alters the gating of human and mouse -bungarotoxin-sensitive nicotinic receptorsThe Journal of Physiology, 2003
- Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptidesPeptides, 2002
- α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's DiseaseJournal of Neurochemistry, 1999
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Nicotine Inhibits Amyloid Formation by the β-PeptideBiochemistry, 1996
- Smoking and Alzheimer's Disease: A Review of the Epidemiological EvidenceNeuroepidemiology, 1994
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human BrainJournal of Neurochemistry, 1988
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984